TG Therapeutics reported 237K in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
TG Therapeutics TGTX:US 237K 27K
Abbvie ABBV:US $ 4021M 259M
Amgen AMGN:US $ 1561M 157M
Ardelyx ARDX:US $ 0.08M 0.08M
Bayer BAYN:GR € 5176M 1491M
Biogen BIIB:US $ 753.9M 93.8M
Corcept Therapeutics CORT:US $ 1.25M 0.1M
Curis CRIS:US $ 0.08M 0.08M
Dynavax Technologies DVAX:US $ 39.96M 34.05M
Gilead Sciences GILD:US $ 1424M 1203M
Infinity Pharmaceuticals INFI:US $ 0.39M 0.12M
Intercept Pharmaceuticals ICPT:US $ 0.76M 0.26M
Johnson & Johnson JNJ:US $ 7598M 357M
Karyopharm Therapeutics KPTI:US $ 1.43M 684K
Novartis NOVN:VX SF 3755M 245M
Ptc Therapeutics PTCT:US $ 10.14M 0.81M
Puma Biotechnology PBYI:US $ 10.84M 1.05M
Regeneron Pharmaceuticals REGN:US $ 404.9M 577.7M
Vertex Pharmaceuticals VRTX:US $ 245.8M 1.59M